Abstract: To construct a prediction model of pathologic complete response (pCR) in locally advanced rectal cancer patients who received programmed cell death protein-1 (PD-1) antibody and total neoadjuvant chemoradiotherapy by using radiomics based on MR imaging data and to investigate its predictive value. A clinical diagnostic test study was carried out. Clinicopathalogical and radiological data of 38 patients with middle-low rectal cancer who received PD-1 antibody combined with total neoadjuvant chemoradiotherapy and underwent TME surgery from January 2019 to September 2021 in our hospital were retrospectively collected. Among 38 patients, 23 were males and 15 were females with a median age of 68 (47-79) years and 13 (34.2%) a chieved pCR. These 38 patients were stratified and randomly divided into the training group (=26) and test group (=12) for modeling. All the patients underwent rectal MRI before treatment. The clinical, imaging and radiomics features of all the patients were collected, and the clinical feature model and radiomics model were constructed. The receiver operating characteristic (ROC) curves of each model were drawn, and the constructed model was evaluated through the area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value and negative predictive value. There were no significant differences in age, gender, primary location of tumor and postoperative pathology between the two groups (all >0.05). Forty-one features were extracted from region of interest in each modality, including 9 first-order features, 24 gray level co-occurrence matrix features and 8 shape features. From 38 patients, 41 features were extracted from each imaging modality of baseline and preoperative DWI and T2WI images, totally 164 features. Only 4 features were preserved after correlation analysis between each pair of features and t-test between pCR and non-pCR subjects. After LASSO cross validation, only the first-order skewness of the baseline DWI image before treatment and the volume in the baseline T2WI image before treatment were retained. The area under the curve, sensitivity, specificity, positive and negative predictive values of the prediction model established by applying these two features in the training group and the test group were 0.856 and 0.844, 77.8% and 100.0%, 88.2% and 75.0%, 77.8% and 66.7%, 88.2% and 100.0%, respectively. The decision curve analysis of the radiomics model showed that the strategy of this model in predicting pCR was better than that in treating all the patients as pCR and that in treating all the patients as non-pCR. The pCR prediction model for rectal cancer patients receiving PD-1 antibody combined with total neoadjuvant radiochemotherapy based on MRI radiomics has the potential to be used in clinical screening or rectal cancer patients who can be spared from radical surgery.

The Value of Magnetic Resonance Imaging to Diagnose Pathological Complete Response of Rectal Cancer after Therapy

Characteristics And Prognostic Significance Of Preoperative Magnetic Resonance Imaging-Assessed Circumferential Margin In Rectal Cancer

Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial.

Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis

Is There a Benefit in Using Magnetic Resonance Imaging in the Prediction of Preoperative Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer?

The application and research of MRI in the evaluation of treatment response to neoadjuvant chemoradiotherapy in rectal cancer

A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer

A New Magnetic Resonance Imaging Tumour Response Grading Scheme for Locally Advanced Rectal Cancer

[Clinical Value of MR Diffusion Weighted Imaging in Prediction of Pathological Complete Response of Rectal Cancer after Neoadjuvant Therapy].

[Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer]

Can rectal MRI and endorectal ultrasound accurately predict the complete response to neoadjuvant immunotherapy for rectal cancer?

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection

Application value of different sequences magnetic resonance imaging in rectal cancer re-staging after neoadjuvant chemoradiation therapy

Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer

Diffusion-weighted Magnetic Resonance Imaging for Predicting the Response of Rectal Cancer to Neoadjuvant Concurrent Chemoradiation

[A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].

Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT

Dynamic Contrast-Enhanced Mri: Use in Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

The Diagnostic Accuracy of Magnetic Resonance Imaging in Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Patients with Different Molecular Subtypes of Breast Cancer.

Predicting treatment response for the safe non-operative management of patients with rectal cancer using an MRI-based deep-learning model.

[Meta-Analysis of Diagnostic Accuracy of Magnetic Resonance in Restaging of Rectal Cancer after Preoperative Chemoradiotherapy].